title: Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs.
abstract: We investigated the protective effect of ischaemic preconditioning (IP) on the maintenance of coronary patency using on-line measurements of coronary pressures and blood flow in a closed-chest reperfused acute myocardial infarction (MI) model in pigs. Catheter-based 90-min occlusion followed by 60-min reperfusion of the left anterior descending coronary artery (LAD) was performed in anesthetised pigs (MI group). IP was applied (IP group) through two cycles of 5-min occlusion and 5-min reperfusion of the LAD before MI induction. Coronary patency was determined by measurements of coronary wedge pressure, collateral fractional flow reserve (FFRcoll), collateral pressure index (CPI) and absolute coronary blood flow (CBF). Inducible and constitutive nitric oxide synthase (iNOS/cNOS) activities and expressions were determined in the myocardium. Plasma levels of myeloperoxidase (MPO, index of activated leukocytes) and mean platelet volume (MPV, index of activated platelets) were measured. IP resulted in significantly lower levels of MPO (0.52 +/- 0.19 vs. 1.05 +/- 0.24 U/l, p<0.001) and MPV (9.1 +/- 0.6 vs. 9.6 +/- 1.0 fl, p=0.04), higher FFRcoll (0.17 +/- 0.05 vs. 0.04 +/- 0.05, p<0.001), CPI (0.13 +/- 0.05 vs. 0.02 +/- 0.05, p<0.001) and CBF (70.7 +/- 4.2 vs. 50.8 +/- 4.8 m/min, p<0.001) post-reperfusion as compared with the MI group. IP resulted in significantly higher cNOS activity and eNOS expression. Significant negative correlation was found between MPO and measures of coronary patency (FFRcoll, CPI and CBF) and cNOS activity. Moreover, cNOS activity correlated significantly with FFRcoll, CPI and CBF. In conclusion, IP attenuates the release of MPO and platelet activation, thereby contributing to the maintenance of vessel patency at microvascular level after reperfusion of the infarct-related artery.
authors.affiliation: Department of Cardiology, Medical University of Vienna, Austria, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Posa
authors.forename: N
authors.initials: N
authors.lastname: Pavo
authors.forename: R
authors.initials: R
authors.lastname: Hemetsberger
authors.forename: C
authors.initials: C
authors.lastname: Csonka
authors.forename: T
authors.initials: T
authors.lastname: Csont
authors.forename: P
authors.initials: P
authors.lastname: Ferdinandy
authors.forename: Z
authors.initials: Z
authors.lastname: Petrási
authors.forename: C
authors.initials: C
authors.lastname: Varga
authors.forename: I J
authors.initials: IJ
authors.lastname: Pavo
authors.forename: F
authors.initials: F
authors.lastname: Laszlo
authors.forename: K
authors.initials: K
authors.lastname: Huber
authors.forename: M
authors.initials: M
authors.lastname: Gyöngyösi
mesh_terms: D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure; D003326:Coronary Circulation / Q000502:physiology*; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D008833:Microcirculation; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology; D009195:Peroxidase / Q000097:blood; D015539:Platelet Activation; D013552:Swine; D014654:Vascular Patency
chemical_list: D009195:Peroxidase